Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
1,124
+7
+0.6% +$1.76K 0.06% 60
2026
Q1
$266K Buy
1,117
+7
+0.6% +$1.89K 0.05% 63
2025
Q4
$338K Sell
1,110
-104
-9% -$31.1K 0.07% 55
2025
Q3
$361K Buy
1,214
+206
+20% +$53.9K 0.07% 60
2025
Q2
$292K Buy
1,008
+5
+0.5% +$1.29K 0.06% 66
2025
Q1
$240K Buy
1,003
+45
+5% +$11K 0.06% 63
2024
Q4
$213K Buy
958
+6
+0.6% +$1.34K 0.05% 75
2024
Q3
$222K Buy
952
+8
+0.8% +$1.57K 0.05% 74
2024
Q2
$166K Buy
944
+9
+1% +$1.56K 0.04% 80
2024
Q1
$158K Sell
935
-11
-1% -$2.01K 0.04% 83
2023
Q4
$158K Sell
946
-305
-24% -$46.1K 0.05% 81
2023
Q3
$178K Buy
1,251
+13
+1% +$1.85K 0.07% 83
2023
Q2
$165K Buy
1,238
+12
+1% +$1.55K 0.07% 89
2023
Q1
$161K Buy
1,226
+172
+16% +$23K 0.07% 91
2022
Q4
$148K Sell
1,054
-7
-0.7% -$966 0.07% 93
2022
Q3
$125K Buy
1,061
+12
+1% +$1.57K 0.08% 93
2022
Q2
$148K Buy
1,049
+7
+0.7% +$945 0.1% 89
2022
Q1
$130K Hold
1,042
0.08% 98
2021
Q4
$130K Sell
1,042
-37
-3% -$4.64K 0.08% 98
2021
Q3
$123K Buy
+1,079
New +$144K 0.07% 99

Other funds holding IBM

Kozak & Associates's IBM Position: Q2 2026 in Review

Kozak & Associates increased its IBM (IBM) stake by 0.63% in Q2 2026, buying an estimated $1.76K and bringing the position to 1,124 shares worth $322K. The position accounts for 0.06% of the portfolio, ranked #60.

Kozak & Associates first reported a position in IBM in Q3 2021 and has held it in 20 quarters since. The position peaked at $361K in Q3 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Kozak & Associates held 1,124 shares of IBM worth $322K as of Q2 2026.
  • Kozak & Associates bought 7 IBM shares in Q2 2026, an estimated $1.76K.
  • IBM made up 0.06% of Kozak & Associates's portfolio in Q2 2026, its #60 holding.
  • Kozak & Associates first reported a position in IBM in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's IBM position peaked at $361K in Q3 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.